This component of the program is made possible through Sanofi Cares North America. M05.60, M05.611, M05.612, M05.619, M05.621, M05.622, M05.629, M05.631, M05.632, M05.639, M05.641, M05.642, M05.649, M05.651, M05.652, M05.659, M05.661, M05.662, M05.669, M05.671, M05.672, M05.679, M05.69, M05.70, M05.711, M05.712, M05.719, M05.721, M05.722, M05.729, M05.731, M05.732, M05.739, M05.741, M05.742, M05.749, M05.751, M05.752, M05.759, M05.761, M05.762, M05.769, M05.771, M05.772, M05.779, M05.79, M05.80, M05.811, M05.812, M05.819, M05.821, M05.822, M05.829, M05.831, M05.832, M05.839, M05.841, M05.842, M05.849, M05.851, M05.852, M05.859, M05.861, M05.862, M05.869, M05.871, M05.872, M05.879, M05.89, M05.9, M06.00, M06.011, M06.012, M06.019, M06.021, M06.022, M06.029, M06.031, M06.032, M06.039, M06.041, M06.042, M06.049, M06.051, M06.052, M06.059, M06.061, M06.062, M06.069, M06.071, M06.072, M06.079, M06.08, M06.09, M06.4, M06.80, M06.811, M06.812, M06.819, M06.821, M06.822, M06.829, M06.831, M06.832, M06.839, M06.841, M06.842, M06.849, M06.851, M06.852, M06.859, M06.861, M06.862, M06.869, M06.871, M06.872, M06.879, M06.88, M06.89, M06.9, M08.00, M08.011, M08.012, M08.019, M08.021, M08.022, M08.029, M08.031, M08.032, M08.039, M08.041, M08.042, M08.049, M08.051, M08.052, M08.059, M08.061, M08.062, M08.069, M08.071, M08.072, M08.079, M08.09, M08.20, M08.211, M08.212, M08.219, M08.221, M08.222, M08.229, M08.231, M08.232, M08.239, M08.241, M08.242, M08.249, M08.251, M08.252, M08.259, M08.261, M08.262, M08.269, M08.271, M08.272, M08.279, M08.28, M08.29, M08.40, M08.411, M08.412, M08.419, M08.421, M08.422, M08.429, M08.431, M08.432, M08.439, M08.441, M08.442, M08.449, M08.451, M08.452, M08.459, M08.461, M08.462, M08.469, M08.471, M08.472, M08.479 Rheumatoid arthritis (RA) is an inflammatory disorder in which the immune system attacks its own tissues. Hydroxychloroquine medical definition Chloroquine wikipedia Methotrexate and plaquenil for lupus Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. Today, it is used to treat rheumatoid arthritis, some symptoms of lupus, childhood arthritis or juvenile idiopathic arthritis and other autoimmune diseases. HYDROXYCHLOROQUINE - ORAL hi-DROX-ee-KLOR-oh-kwin COMMON BRAND NAMES Plaquenil. Uses. This medication is used to treat rheumatoid arthritis and lupus; and to treat or prevent malaria. How To Use. Take this medication with food to prevent stomach upset. Take this medication exactly as prescribed. Do not stop taking it without consulting your doctor. Financial criteria for patient assistance. In order to meet the financial eligibility criteria for receiving Sanofi medication at no cost, you must have an annual household income of ≤ 250% of the current Federal Poverty Level. Patient Assistance Connection Financial Eligibility for uninsured or functionally uninsured patients Determine. How to Apply: Select one of the links below to download the application or go to the program site for more information on how to apply. RA is a chronic disease that affects the immune system. Hydroxychloroquine assistance program Plaquenil Prices, Coupons & Patient Assistance Programs., PLAQUENIL Patient Assistance Program Plaquenil for hivesChloroquine phosphate fish suicideHydroxychloroquine lupus erythematosus Patient Assistance Programs for Hydroxychloroquine. Patient assistance programs PAPs are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program. There are currently no Patient Assistance Programs that we know about for this drug. Hydroxychloroquine Prices, Coupons & Patient Assistance.. Financial Eligibility Sanofi Patient Connection®. Hydroxychloroquine sulfate 200mg copay assistance – a code. To qualify for PAN’s travel assistance programs, the patient must be required to travel more than 20 miles one way to receive his or her prescribed treatment. Exceptions to distance requirements are made for patients living in large metropolitan cities. See PAN’s Travel FAQs for details. The patient is eligible for assistance for 12 months. If additional assistance is requested, a new application must be submitted to the hotline. In circumstances of significant financial need and serious medical hardship, individuals, with the help of their doctor, may appeal from denial of participation in this program including denials based on Medicare Part D coverage. The patient must be getting treatment for systemic lupus erythematosus. The patient must have health insurance that covers his or her qualifying medication or product. The patient’s medication or product must be listed on PAN’s list of covered medications. The patient’s income must fall at or below 500% of the Federal Poverty Level.